Loss of kindlin-3 alters the threshold for NK cell activation in human leukocyte adhesion deficiency-III

Blood

Volumn 120, Issue 19, 2012, Pages 3915-3924

  Gruda, Raizy ^a   Brown, Alice C N ^b   Grabovsky, Valentin ^c   Mizrahi, Saar ^a   Gur, Chamutal ^e   Feigelson, Sara W ^c   Achdout, Hagit ^a   Bar on, Yotam ^a   Alon, Ronen ^c   Aker, Memet ^d   Davis, Daniel M ^b   Mandelboim, Ofer ^a  

^a HEBREW UNIVERSITY   (Israel)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

F ACTIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; KINDLIN 3; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; CELL ADHESION; CELL MIGRATION; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE ADHESION DEFICIENCY; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPSE;

EID: 84868608902     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-02-410795     Document Type: Article

References (48)

1. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76(2):301-314. (Pubitemid 24046692)
2. Bromley SK, Burack WR, Johnson KG, et al. The immunological synapse. Annu Rev Immunol. 2001;19:375-396. (Pubitemid 32368040)
3. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell. 1998;94(5):657-666. (Pubitemid 28427584)
4. Davis DM. Mechanisms and functions for the duration of intercellular contacts made by lymphocytes. Nat Rev Immunol. 2009;9(8):543-555.
5. Luo BH, Carman CV, Springer TA. Structural basis of integrin regulation and signaling. Annu Rev Immunol. 2007;25:619-647. (Pubitemid 46697919)
6. Critchley DR, Gingras AR. Talin at a glance. J Cell Sci. 2008;121(9):1345-1347. (Pubitemid 351936298)
7. Ma YQ, Qin J, Wu C, Plow EF. Kindlin-2 (Mig-2): a co-activator of beta3 integrins. J Cell Biol. 2008; 181(3):439-446. (Pubitemid 351645034)
8. Montanez E, Ussar S, Schifferer M, et al. Kindlin-2 controls bidirectional signaling of integrins. Genes Dev. 2008;22(10):1325-1330. (Pubitemid 351717522)
9. Moser M, Nieswandt B, Ussar S, Pozgajova M, Fassler R. Kindlin-3 is essential for integrin activation and platelet aggregation. Nat Med. 2008; 14(3):325-330. (Pubitemid 351347914)
10. Harburger DS, Bouaouina M, Calderwood DA. Kindlin-1 and -2 directly bind the C-terminal region of beta integrin cytoplasmic tails and exert integrin-specific activation effects. J Biol Chem. 2009;284(17):11485-11497.
11. Ussar S, Wang HV, Linder S, Fassler R, Moser M. The Kindlins: subcellular localization and expression during murine development. Exp Cell Res. 2006;312(16):3142-3151. (Pubitemid 44292664)
12. Kuijpers TW, van de Vijver E, Weterman MA, et al. LAD-1/variant syndrome is caused by mutations in FERMT3. Blood. 2009;113(19):4740-4746.
13. Svensson L, Howarth K, McDowall A, et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation. Nat Med. 2009;15(3):306-312.
14. Malinin NL, Zhang L, Choi J, et al. A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. Nat Med. 2009;15(3): 313-318.
15. Manevich-Mendelson E, Feigelson SW, Pasvolsky R, et al. Loss of Kindlin-3 in LAD-III eliminates LFA-1 but not VLA-4 adhesiveness developed under shear flow conditions. Blood. 2009;114(11):2344-2353.
16. McDowall A, Svensson L, Stanley P, et al. Two mutations in the KINDLIN3 gene of a new leukocyte adhesion deficiency III patient reveal distinct effects on leukocyte function in vitro. Blood. 2010; 115(23):4834-4842.
17. Jurk K, Schulz AS, Kehrel BE, et al. Novel integrin- dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3. Thromb Haemost. 2010;103(5):1053-1064.
18. Robert P, Canault M, Farnarier C, et al. A novel leukocyte adhesion deficiency III variant: kindlin-3 deficiency results in integrin- and nonintegrin-related defects in different steps of leukocyte adhesion. J Immunol. 2011;186(9):5273-5283.
19. Feigelson SW, Grabovsky V, Manevich-Mendelson E, et al. Kindlin-3 is required for the stabilization of TCR-stimulated LFA-1:ICAM-1 bonds critical for lymphocyte arrest and spreading on dendritic cells. Blood. 2011;117(26):7042- 7052.
20. van de Vijver E, Maddalena A, Sanal O, et al. Hematologically important mutations: leukocyte adhesion deficiency (first update). Blood Cells Mol Dis. 2012;48(1):53-61.
21. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187-376. (Pubitemid 20010960)
22. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature. 2009; 457(7229):557-561.
23. Paust S, von Andrian UH. Natural killer cell memory. Nat Immunol. 2011;12(6):500-508.
24. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. 2008;9(5): 495-502. (Pubitemid 351560518)
25. Eissmann P, Davis DM. Inhibitory and regulatory immune synapses. Curr Top Microbiol Immunol. 2010;340:63-79.
26. Orange JS. Formation and function of the lytic NK-cell immunological synapse. Nat Rev Immunol. 2008;8(9):713-725.
27. + natural killer cells. Blood. 2004;104(4):1083-1093.
28. Barber DF, Faure M, Long EO. LFA-1 contributes an early signal for NK cell cytotoxicity. J Immunol. 2004;173(6):3653-3659. (Pubitemid 39280725)
29. Mandelboim O, Reyburn HT, Vales-Gomez M, et al. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J Exp Med. 1996;184(3):913-922.
30. Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. Proc Natl Acad Sci U S A. 1999; 96(10):5640-5644. (Pubitemid 29234671)
31. Culley FJ, Johnson M, Evans JH, et al. Natural killer cell signal integration balances synapse symmetry and migration. PLoS Biol. 2009;7(7): e1000159.
32. Porgador A, Mandelboim O, Restifo NP, Strominger JL. Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy. Proc Natl Acad Sci U S A. 1997;94(24):13140-13145. (Pubitemid 27518489)
33. Alon R, Etzioni A. LAD-III, a novel group of leukocyte integrin activation deficiencies. Trends Immunol. 2003;24(10):561-566. (Pubitemid 37205208)
34. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 1990; 248(4952):220-223. (Pubitemid 120031455)
35. Achdout H, Meningher T, Hirsh S, et al. Killing of avian and swine influenza virus by natural killer cells. J Virol. 2010;84(8):3993-4001.
36. Bryceson YT, Ljunggren HG, Long EO. Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors. Blood. 2009;114(13):2657-2666.
37. Alon R, Feigelson S. From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin Immunol. 2002;14(2):93-104. (Pubitemid 34879385)
38. Dransfield I, Cabanas C, Craig A, Hogg N. Divalent cation regulation of the function of the leukocyte integrin LFA-1. J Cell Biol. 1992;116(1):219-226.
39. Moser M, Bauer M, Schmid S, et al. Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to endothelial cells. Nat Med. 2009; 15(3):300-305.
40. Bryceson YT, March ME, Ljunggren HG, Long EO. Activation, coactivation, and costimulation of resting human natural killer cells. Immunol Rev. 2006;214: 73-91. (Pubitemid 44707903)
41. Castriconi R, Dondero A, Cantoni C, et al. Functional characterization of natural killer cells in type I leukocyte adhesion deficiency. Blood. 2007; 109(11):4873-4881. (Pubitemid 46827784)
42. Bryceson YT, March ME, Ljunggren HG, Long EO. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood. 2006;107(1):159-166. (Pubitemid 43053538)
43. Biassoni R, Cantoni C, Pende D, et al. Human natural killer cell receptors and co-receptors. Immunol Rev. 2001;181:203-214. (Pubitemid 32703408)
44. Bryceson YT, March ME, Barber DF, Ljunggren HG, Long EO. Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J Exp Med. 2005;202(7):1001-1012. (Pubitemid 41396899)
45. Das A, Long EO. Lytic granule polarization, rather than degranulation, is the preferred target of inhibitory receptors in NK cells. J Immunol. 2010; 185(8):4698-4704.
46. Lefort CT, Rossaint J, Moser M, et al. Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation. Blood. 2012;119(18):4275-4282.
47. Graham DB, Cella M, Giurisato E, et al. Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics. J Immunol. 2006;177(4):2349-2355. (Pubitemid 44200995)
48. Chaushu S, Wilensky A, Gur C, et al. Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease. PLoS Pathog. 2012;8(3):e1002601.